NM_007348.4:c.1804+913G>A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_007348.4(ATF6):​c.1804+913G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.21 in 152,042 control chromosomes in the GnomAD database, including 4,078 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.21 ( 4078 hom., cov: 32)

Consequence

ATF6
NM_007348.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.269

Publications

3 publications found
Variant links:
Genes affected
ATF6 (HGNC:791): (activating transcription factor 6) This gene encodes a transcription factor that activates target genes for the unfolded protein response (UPR) during endoplasmic reticulum (ER) stress. Although it is a transcription factor, this protein is unusual in that it is synthesized as a transmembrane protein that is embedded in the ER. It functions as an ER stress sensor/transducer, and following ER stress-induced proteolysis, it functions as a nuclear transcription factor via a cis-acting ER stress response element (ERSE) that is present in the promoters of genes encoding ER chaperones. This protein has been identified as a survival factor for quiescent but not proliferative squamous carcinoma cells. There have been conflicting reports about the association of polymorphisms in this gene with diabetes in different populations, but another polymorphism has been associated with increased plasma cholesterol levels. This gene is also thought to be a potential therapeutic target for cystic fibrosis. [provided by RefSeq, Aug 2011]
ATF6 Gene-Disease associations (from GenCC):
  • achromatopsia 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae)
  • ATF6-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • achromatopsia
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.279 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATF6NM_007348.4 linkc.1804+913G>A intron_variant Intron 15 of 15 ENST00000367942.4 NP_031374.2 P18850A8K383
ATF6NM_001437597.1 linkc.1861+913G>A intron_variant Intron 15 of 15 NP_001424526.1
ATF6NM_001410890.1 linkc.1801+913G>A intron_variant Intron 15 of 15 NP_001397819.1
ATF6XM_011509309.1 linkc.1858+913G>A intron_variant Intron 15 of 15 XP_011507611.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATF6ENST00000367942.4 linkc.1804+913G>A intron_variant Intron 15 of 15 1 NM_007348.4 ENSP00000356919.3 P18850

Frequencies

GnomAD3 genomes
AF:
0.210
AC:
31937
AN:
151924
Hom.:
4081
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0638
Gnomad AMI
AF:
0.371
Gnomad AMR
AF:
0.198
Gnomad ASJ
AF:
0.219
Gnomad EAS
AF:
0.275
Gnomad SAS
AF:
0.165
Gnomad FIN
AF:
0.304
Gnomad MID
AF:
0.255
Gnomad NFE
AF:
0.283
Gnomad OTH
AF:
0.216
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.210
AC:
31928
AN:
152042
Hom.:
4078
Cov.:
32
AF XY:
0.211
AC XY:
15646
AN XY:
74318
show subpopulations
African (AFR)
AF:
0.0636
AC:
2639
AN:
41494
American (AMR)
AF:
0.198
AC:
3026
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.219
AC:
758
AN:
3466
East Asian (EAS)
AF:
0.276
AC:
1427
AN:
5176
South Asian (SAS)
AF:
0.165
AC:
795
AN:
4812
European-Finnish (FIN)
AF:
0.304
AC:
3206
AN:
10562
Middle Eastern (MID)
AF:
0.257
AC:
75
AN:
292
European-Non Finnish (NFE)
AF:
0.283
AC:
19215
AN:
67942
Other (OTH)
AF:
0.213
AC:
449
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1255
2511
3766
5022
6277
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
334
668
1002
1336
1670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.227
Hom.:
2846
Bravo
AF:
0.198
Asia WGS
AF:
0.201
AC:
698
AN:
3472

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
5.0
DANN
Benign
0.44
PhyloP100
0.27
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4657121; hg19: chr1-161883083; API